article thumbnail

Japanese Officials Approve Epidiolex For Clinical Trials

Cannabis Law Report

The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Ministry of Health, Labor and Welfare officials recently announced the trials during a meeting of the Okinawa-Northern Task Force, a research and development agency.

article thumbnail

Flora Growth Forms Flora Pharma Division, Launches Global Clinical Trials

Cannabis Law Report

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. Forward-looking statements are only predictions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What A Surprise …Not. “TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions”

Cannabis Law Report

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. “I agree with the committee that the preliminary findings from clinical trials — although still in early phases — evaluated by the panel are promising,” the decision’s author said.

article thumbnail

Volteface: Strengthening the European Psychedelic Ecosystem: Partnership Between Octarine Bio and Clerkenwell Health

Cannabis Law Report

We’re thrilled to be working with a company that shares our vision and is committed to making Europe a leader in the field by providing world-class clinical expertise tailored to the nuances of psychedelic therapy.

article thumbnail

European Regulatory Lead MAPS PBC Santa Cruz, CA

Cannabis Law Report

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. European Regulatory Lead Executive Summary. Key Responsibilities.

article thumbnail

Press Release: Psychedelic startup Mindstate’s $11.5M trip

Cannabis Law Report

Context: Psychedelics are hot right now, thanks to factors including: Clinical trials linking them to positive results in people with depression and PTSD. A regulatory environment that’s seeing some forms of the drugs legalized in certain instances, such as for medicinal and tribal uses.

article thumbnail

Husch Blackwell Launches Psychedelics and Emerging Therapies Practice Group

Cannabis Law Report

Similar to the early days of the medical cannabis movement, psychedelic drugs such as MDMA, psilocybin, LSD, ketamine and DMT are being developed for therapeutic use in a complex and difficult legal and regulatory environment. The firm’s multidisciplinary team covers commercial, regulatory and legal requirements spanning U.S.

Therapy 52